Fat Metabolism & Peptide Support

LIPOLYTIC PEPTIDE

FAT LOSS

500 MCG-1-MG

5 DAYS ON, 2 OFF

SUBCUTANEOUS

FASTED BEFORE BED OR UPON WAKING (FASTED CARDIO)

WHY CHOOSE AOD-9604

When it comes to targeted fat loss and body contouring AOD-9064 offers unique advantages that set it apart from other welness treatments.

TARGETED FAT LOSS

AOD-9064 is known for its ability to target and reduce fat stores without affecting appetite.

METABOLIC BOOST

It helps stimulate your metabolism, promoting more efficient fat burning.

SAFE & WELL-TOLERATED

It works on fat cells without affecting blood sugar levels or growth.

CARTILAGE REPAIR

AOD-9064 has also been studied for its potential to support cartilage and joint health.

CAN AOD-9604 BE USED
WITH OTHER WEIGHT LOSS PEPTIDES?

Yes, AOD-9604 is often combined with peptides like Semaglutide or Ipamorelin for enhanced fat loss and metabolic regulation.

AMYLIN ANALOG PEPTIDE

APPETITE CONTROL

300 MCG-4.5 MG

ONCE PER WEEK

SUBCUTANEOUS

CAN BE ADDED TO GLP TO INCREASE SYNERGISTIC EFFECT

WHY CHOOSE CAGRILINTIDE

Cagrilintide is a next-generation metabolic peptide designed to regulate appetite, support weight loss, and enhance glucose metabolism. It functions by mimicking the action of amylin, targeting specific regions in the brain that regulate appetite and gastric emptying.

This analogue binds to the amylin receptor with high affinity, leading to:

Slower gastric emptying

Enhanced satiety

Decreased caloric intake

cagrilintide + semaglutide —targets both amylin and GLP-1 pathways for enhanced weight and metabolic benefits.

BENEFITS: WHAT’S IN IT FOR PATIENTS?

1

Superior weight loss: The combination consistently achieves ~20–23% weight reduction, outperforming either drug alone and placing it among the strongest results in the obesity pharmacotherapy landscape (Reuters; tctmd.com; Applied Clinical Trials Online; PubMed).

2

Meaningful metabolic gains: Improvements have been seen in glycemic control (HbA1c), blood pressure, lipids, and inflammation markers, with more patients returning to normoglycemia (Reuters; tctmd.com; PubMed).

3

Mechanistic synergy: GLP-1 agonists such as semaglutide slow gastric emptying, suppress glucagon, and increase insulin, while cagrilintide enhances satiety and further slows digestion via amylin pathways—together providing complementary effects (The Innovation; Pharmacy Times; Wikipedia).

4

Safety profile: Adverse effects are mainly GI, mild to moderate, and transient—consistent with GLP-1 profiles and most commonly involves nausea and constipation.

MITOCHONDRIAL DERIVED PEPTIDE

METABOLIC ENHANCEMENT

5-10 MG

1 INJECTION EVERY 5 DAYS FOR 20 DAYS

SUBCUTANEOUS

HOW IT WORKS?

MOTS-c functions by targeting pathways that are critical for metabolic balance. It helps promote insulin sensitivity, allowing your body to use glucose more effectively and store less fat.

THE SCIENCE BEHIND IT

MOTS-c is a mitochondrial-derived peptide that regulates metabolic pathways and helps with the proper utilization of fatty acids for energy. It essentially tells your cells to burn fat for fuel, not just glucose.

WHAT IS MOTS-c

It is a naturally occurring peptide that helps regulate metabolism througout your body. It plays a vital role in cellular energy production, ensuring your cells have the fuel they need to function at their best.

POTENTIAL BENEFITS TO YOU

METABOLIC HEALTH

Improves insulin sensitivity and glucose regulation Supports weight management by enhancing fat and energy metabolism

ENERGY & PHYSICAL PERFORMANCE

Boosts exercise capacity and endurance May reduce fatigue and improve recovery

CELLULAR PROTECTION

Provides antioxidant effects, reducing oxidative stress Promotes healthy aging by supporting mitochondrial health May protect against age-related decline in metabolic function

BRAIN & COGNITIVE SUPPORT

Preclinical evidence suggests neuroprotective effects May help with stress adaptation and mental clarity

TRIPLE AGONIST PEPTIDE

METABOLISM BOOST

2-12 MG

ONCE PER WEEK

SUBCUTANEOUS

SAME DAY EVERY WEEK

Survodutide is a dual-action peptide designed to regulate appetite and enhance metabolic function, making it highly effective for weight loss and fat reduction.

This peptide works by targeting both glucagon and GLP-1 receptors, helping to reduce hunger, increase satiety, and promote the breakdown of stored fat for energy.

CLINICAL EVIDENCE

Preclinical trials on Survodutide have indicated significant reductions in overall body mass, with particular reductions in visceral fat deposits. This outcome is enhanced by:

Decreased meal size

Improved lipid profile

Better glucose homeostasis

Survodutide has shown promise in improving glucose metabolism and insulin sensitivity, making it beneficial for individuals managing weight-related conditions such as obesity and type 2 diabetes.

In addition to its metabolic benefits, Survodutide may help improve cardiovascular health by reducing excess body fat and promoting healthier lipid profiles.

TRIPLE AGONIST PEPTIDE

METABOLISM
BOOST

2-12 MG

ONCE PER WEEK

SUBCUTANEOUS

SAME DAY EVERY WEEK

WHAT IS RETATRUTIDE?

Retatrutide is a once-weekly injectable medication currently in clinical trials. It activates three key hormone receptors involved in metabolic health:

GLP-1 (Glucagon-Like Peptide-1):

Reduces appetite, improves insulin sensitivity

GIP (Glucose-Dependent Insulinotropic Polypeptide):

Supports insulin release and metabolic balance

Glucagon Receptor:

Increases energy expenditure, promotes fat breakdown

This triple-agonist approach is designed to produce greater and faster weight loss than all other therapies.

BENEFITS OF

RETATRUTIDE

DISCLAIMERS

Peptides may not be FDA approved

These statements have not been evaluated by the Food and Drug Administration. The products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.

Some peptides are not FDA-approved for anti-aging, weight loss, or wellness indications. Some have FDA approval for very specific conditions (e.g., tesamorelin for HIV-related lipodystrophy), but using them outside of that is considered off-label.

Some peptides are considered investigational and are only available via prescription from a licensed provider.

Medical Advice

The content on this website is for informational and educational purposes only and should not be considered medical advice.

Individual results may vary. Always consult with your healthcare provider before starting any new treatment.

Compounding Disclaimer

Certain peptides are only available through compounding pharmacies.

Compounded medications are not FDA-approved but are prepared under strict regulatory standards with a prescription.

Research Use Off-Label Disclaimer

Some therapies discussed involve off-label use of FDA-approved medications or investigational compounds.

Off-label use means the medication is being used in a manner not specifically approved by the FDA.